Displaying 41 to 60 of 644 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Alion Energy Photovoltaic (solar) power plants |
United States | N/A Active |
||
|
Allegro |
N/A Active |
|||
|
|
Alpha and Omega Semiconductor |
United States | N/A Active |
||
|
|
Altos Computer Systems |
United States | N/A Active |
||
|
|
Ameritox Ltd Leader in pain medication monitoring, offering urine drug testing services. |
United States | N/A Active |
||
|
|
Amobee Inc |
United States | N/A Active |
||
|
|
Amylin Pharmaceuticals Inc |
United States | N/A Active |
||
|
Anterior Inc Developer of AI tools designed to handle various administrative workflows for healthcare professionals |
United States | 8 Jun 2024 | Series A Initial investment. Round participant. Active |
|
|
|
Aobi Children's social networking services |
China | 31 Mar 2010 | N/A Active |
|
|
|
AoTian Mobile travel management services |
China | N/A Active |
||
|
|
Appirio Inc SaaS systems integration services |
United States | 20 Jun 2008 | N/A Active |
|
|
Apple Inc Designer and manufacturer of consumer electronics, computer software, and personal computers. |
United States | 31 Dec 1978 | N/A Initial investment. Round participant. Active |
|
|
Applied Micro Circuits Corp |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Ardent Communications Corp |
United States | N/A Active |
||
|
|
Aricent Group Independent communications software company |
United States | 1 Sep 2006 | N/A Active |
|
|
Armo BioSciences Inc Late-stage immuno-oncology company. |
1 Sep 2017 | Series C-1 Initial investment. Round participant. Active |
||
|
|
Aruba Networks Inc Delivers enterprise network access to users |
United States | 19 Apr 2002 | N/A Active |
|
|
Aspect Development |
United States | N/A Initial investment. Round participant. Exited (Trade sale) |
||
|
|
Assured Access Technology Inc Developer of Internet access switching platforms for ISPs. |
United States | N/A Active |
||
|
AssureRx Health Inc Personalized medicine company specializing in pharmacogenetics |
United States | 25 Mar 2011 | Series B Active |